| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e388911162aa60ca4fbf1d0dc2a6bca1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7c7159366be37ecf8a4c595cfa235a8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate |
1999-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e82d4966fbdc41b9799c2320204ac118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae8e746e364d551ef4c1926194adf090 |
| publicationDate |
2000-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2336486-A1 |
| titleOfInvention |
Hla-a2 restricted tumor antigen peptide originated from sart-1 |
| abstract |
An HLA-A2 restraint tumor antigen peptide originating in SART-1 and its derivative having functional characteristics comparable thereto; remedies, preventives or diagnostics for tumor with the use of the tumor antigen peptide, etc.; recombinant DNAs, recombinant peptides and antibodies relating to the tumor antigen peptide and use of the same; antigen presenting cells presenting the tumor antigen peptide and use of the same; and cytotoxic T cells specific to the tumor antigen peptide and use of the same. |
| priorityDate |
1998-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |